IMMUNE RESPONSE TO COVID 19 VACCINATION

Clinical trials for IMMUNE RESPONSE TO COVID 19 VACCINATION explained in plain language.

Never miss a new study

Get alerted when new IMMUNE RESPONSE TO COVID 19 VACCINATION trials appear

Sign up with your email to follow new studies for IMMUNE RESPONSE TO COVID 19 VACCINATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a peptide supercharge COVID-19 vaccines for seniors?

⭐️ VACCINE ⭐️ Recruiting now

This study tests whether an experimental immune-boosting peptide called thymalfasin (Ta1) can safely enhance the immune response to a COVID-19 mRNA booster shot in adults aged 65 and older. Participants receive different doses of Ta1 before vaccination to see if it improves antib…

Matched conditions: IMMUNE RESPONSE TO COVID 19 VACCINATION

Phase: PHASE1 • Sponsor: The Methodist Hospital Research Institute • Aim: ⭐️ VACCINE ⭐️

Last updated Jul 18, 2026 00:00 UTC

IMMUNE RESPONSE TO COVID 19 VACCINATION

Get alerted when new IMMUNE RESPONSE TO COVID 19 VACCINATION trials appear

Could a peptide supercharge COVID-19 vaccines for seniors?